Profile Image

Dr Kelly Kiejda

Research Fellow

School of Biomedical Sciences and Pharmacy (Medical Genetics)

Cancer crusader

Dr Kelly Avery-Kiejda hopes to improve diagnosis and treatment for breast cancer sufferers by identifying new biomarkers for the disease.

Kelly Avery-Kiejda in the laboratory 

A protein known as 'the guardian of the genome' has been a source of scientific fascination to molecular biologist Dr Kelly Avery-Kiejda for the past seven years. The P53 protein is so named for its ability to prevent the propagation of mutations that can lead to cancer.

P53 is a tumour suppressor, which can put the brakes on cancer by inhibiting the division of cells with DNA damage. But the protein is deactivated in many types of cancers, neutralising this powerful protection against the disease. Avery-Kiejda's research is focused on gaining a better understanding of the function of the protein and the factors that influence its activation.

Avery-Kiejda's first postdoctoral project in 2005 involved the investigation of isoforms (variants) of P53 and their links to chemotherapy resistance in melanoma. She is now applying that expertise to breast cancer research, looking specifically at the role the protein plays in the progression of advanced cancer, with the aim of developing a better method of diagnosing a cancer's potential to develop metastases.

"P53 isoforms were only discovered in 2005 and there is very little known about their role in breast cancer. We are one of the few groups studying that and, to my knowledge, unique in our emphasis on their role in promoting metastatic disease," Avery-Kiejda points out. "Breast cancer, or any cancer, essentially becomes incurable once a secondary cancer develops, so if we can identify markers that will indicate at an early stage whether a patient is more likely to develop a metastasis, then we can treat that patient differently from the outset."

In a related line of research, Avery-Kiejda is pursuing a project that could expand treatment options for women diagnosed with triple-negative forms of breast cancer, which are resistant to most conventional forms of hormone therapy. Since 2009, she has been a key researcher on a multi-site project funded by the National Breast Cancer Foundation (NBCF) analysing the expression of microRNAs. These small molecules are known to play a role in some cancers and can be used as a prognostic tool. In a novel finding, her team has identified a subset of 27 microRNAs that appear to be irregular in breast cancer patients who have developed lymph node metastases.

"This is a critical and very exciting finding because it means we may be able to use this information either to develop a treatment target or to diagnose secondary cancers earlier," Avery-Kiejda explains. "We have been looking at this specifically in triple-negative breast cancers but it may be applicable to others as well."

Avery-Kiejda's research has attracted the support of key cancer organisations, including Cure Cancer Australia, Cancer Australia and the Melanoma Institute Australia. Her affiliation with the University of Newcastle and the Hunter Medical Research Institute (HMRI) has opened collaborations with influential researchers such as the Australia and New Zealand Breast Cancer Trials Group research director Professor John Forbes and internationally recognised cancer geneticist Professor Rodney Scott.

"Everyone, myself included, knows someone who has been affected by cancer," she notes. "It has always been my dream to do something that will make a difference to patients by contributing to more effective treatment strategies."

Visit the Centre for Cancer

Visit the HMRI website

Kelly Avery-Kiejda in the laboratory

Cancer crusader

Dr Kelly Avery-Kiejda hopes to improve diagnosis and treatment for breast cancer sufferers by identifying new biomarkers for the disease.

Read more

Career Summary

Biography

Research Expertise
Kelly Avery-Kiejda's research interests are: - understanding the molecular mechanisms of cancer development and the resistance of cancer to treatment - understanding how p53 function becomes de-regulated in cancer, in particular, melanoma and breast cancer - the role of miRNAs in advanced breast cancer

Teaching Expertise
Dr Avery-Kiejda is a full-time research academic. Currently, Dr Avery-Kiejda is the mentor of an early career postdoctoral fellow and the supervisor of 4 PhD candidates. - She has been the primary and co-supervisor of 2 Honours students (received 1st class Honours). She was the sole supervisor of 3 undergraduate students for their 3rd year projects in the Biotechnology and Biomedical Science degree. She was a demonstrator for the subject Molecular Genetics (2000).

Administrative Expertise
Journal Peer Review - Reviewer for: Neoplasia, Clinical Cancer Research, Molecular Cancer Therapeutics, International Journal of Cancer, Clinical & Experimental Metastasis, BMC Cancer, Breast Cancer Research, Cell & Tissue Research, British Journal of Cancer Grant Peer review - Member of the Cancer Australia Grant Review Committee (2013) - External assessor for NHMRC project grant funding rounds (2011, 2012, 2014) - Assessor for the Hunter Translation Cancer Research Unit pilot project grant rounds (2012)



Qualifications

  • PhD (Medicine), University of Sydney
  • Bachelor of Science (Biotechnology)(Honours), University of Newcastle

Keywords

  • breast cancer
  • gene expression
  • miRNA
  • p53

Languages

  • English (Mother)

Fields of Research

Code Description Percentage
111299 Oncology and Carcinogenesis not elsewhere classified 40
111201 Cancer Cell Biology 30
111203 Cancer Genetics 30

Professional Experience

Academic appointment

Dates Title Organisation / Department
1/01/2013 -  Membership - Australian Society for Biochemistry and Molecular Biology Australian Society for Biochemistry and Molecular Biology
Australia
1/03/2012 - 1/03/2013 Hunter Translational Cancer Research Unit Fellow University of Newcastle
Australia
1/01/2012 - 31/12/2012 Membership - Organising committee for the 2012 ASMR Cocktail Party, Newcastle, NSW, Australia. Held on the 21st September,c Organising committee for the 2012 ASMR Cocktail Party, Newcastle, NSW, Australia. Held on the 21st September,
Australia
1/01/2012 - 31/12/2012 Membership - Organising committee for the 2012 5th Annual Hunter Cancer Research Symposium, Newcastle, NSW, Australia. Held on 2nd November 2012. Organising committee for the 2012 5th Annual Hunter Cancer Research Symposium, Newcastle, NSW, Australia. Held on 2nd November 2012.
Australia
1/01/2012 - 31/12/2013 Membership - Organising committee for the 2013 Translational Cancer Research Conference, Newcastle, Australia Organising committee for the 2013 Translational Cancer Research Conference, Newcastle, Australia
Australia
1/01/2012 -  Membership - Research Enabling Committee of the Hunter Translational Cancer Research Unit Research Enabling Committee of the Hunter Translational Cancer Research Unit
Australia
1/01/2012 - 31/12/2012 Conference Chair - Session chair at the 2012 5th Annual Hunter Cancer Research Symposium, Newcastle, NSW, Australia. Held on 2nd November 2012. Session chair at the 2012 5th Annual Hunter Cancer Research Symposium, Newcastle, NSW, Australia. Held on 2nd November 2012.
Australia
1/01/2012 -  Membership - Institutional Biosafety Committee Institutional Biosafety Committee
Australia
1/01/2012 -  Membership - The NHMRC Postdoctoral Reference Group The NHMRC Postdoctoral Reference Group
Australia
1/01/2012 - 31/12/2012 Membership - 2012 ASMR Gala Dinner Organising Committee, 7th June, Customs House, Newcastle 2012 ASMR Gala Dinner Organising Committee, 7th June, Customs House, Newcastle
Australia
1/01/2011 -  Membership - Hunter Medical Research Institute Disaster Sub-Plan Committee Hunter Medical Research Institute Disaster Sub-Plan Committee
Australia
1/01/2011 -  Membership - The Australian Microarray and Associated Technologies Association The Australian Microarray and Associated Technologies Association
Australia
1/01/2011 - 31/12/2011 Conference Chair - Session chair at the 2011 4th Annual Hunter Medical Research Institute Cancer Research Program Symposium, Newcastle, NSW, Australia. Held on 4th November, 2011. Session chair at the 2011 4th Annual Hunter Medical Research Institute Cancer Research Program Symposium, Newcastle, NSW, Australia. Held on 4th November, 2011.
Australia
1/01/2011 - 31/12/2011 Membership - Organising committee for the 4th Annual Hunter Medical Research Institute Cancer Research Program Symposium, Newcastle, NSW, Australia Organising committee for the 4th Annual Hunter Medical Research Institute Cancer Research Program Symposium, Newcastle, NSW, Australia
Australia
1/08/2005 - 1/09/2009 Cameron Melanoma Research Fellow Calvary Mater Newcastle Hospital
Australia
1/08/2005 - 1/09/2009 Postdoctoral Research Fellow University of Newcastle
School of Biomedical Sciences and Pharmacy
Australia
1/01/2001 - 31/12/2005 Membership - Australian Society for Medical Research (ASMR) Australian Society for Medical Research (ASMR)
Australia

Membership

Dates Title Organisation / Department
1/01/2013 - 31/12/2013 Membership - 2013 ASMR Gala Dinner Organising Committee, 6th June, Merewether Surfhouse, Newcastle 2013 ASMR Gala Dinner Organising Committee, 6th June, Merewether Surfhouse, Newcastle
Australia

Teaching appointment

Dates Title Organisation / Department
1/02/2000 - 1/06/2000 Laboratory Demonstrator University of Newcastle
School of Environmental and Life Sciences
Australia

Awards

Recipient

Year Award
2001 Australian Postgraduate Award
University of Sydney
2001 Millennium Foundation Stipend Enhancement Grant
Unknown

Recognition

Year Award
2012 Emerging research leaders program
University of Newcastle
1999 Deans Commendation List
University of Newcastle
1998 Most Outstanding Performance in the subject Cell and Molecular Biology
University of Newcastle

Research Award

Year Award
2010 HMRI PULSE Education Prize
Unknown
2006 HMRI Translational Cancer Research Conference Early Career Researcher Poster Award
Hunter Medical Research Institute

Invitations

Speaker

Year Title / Rationale
2015 The Delta-40p53 isoform in breast cancer- friend or foe?
Presented by Ms Brianna Morten on my behalf due to inability to fly because of late stage pregnancy
2015 The role of small p53 isoforms in breast cancer.
2012 MicroRNA expression profiling in triple-negative breast cancer.
Organisation: The 9th International RNAi, MicroRNAs and Single Cell Biology Meeting, 1st-2nd May, 2012, Boston
2012 Small p53 Isoforms- BIG Implications for Prognosis and Treatment Response in Cancer.
Organisation: 22nd Annual Queenstown Molecular Biology Meeting: Cancer Biology Satellite. 26-27th August, 2012, Queenstown
2011 MicroRNA expression profiling in triple-negative breast cancer
Organisation: Pharmacy Australia Centre of Excellence (PACE), School of Pharmacy, The University of Queensland Description: Invited to present my research at the Seminar series for Pharmacy Australia Centre of Excellence (PACE), School of Pharmacy, The University of Queensland, Woolloongabba, QLD. 28th April, 2011.
2008 Small isoforms of p53: Do they contribute to melanoma chemoresistance?
Organisation: Research Seminar Series for the Melanoma Foundation, 15th August 2008., Sydney, NSW
2006 The role of p53 variants in human melanoma
Organisation: The Melanoma and Skin Cancer Research Institute (MASCRI) Seminar Series, 20th October 2006, Sydne y, NSW
Edit

Grants and Funding

Summary

Number of grants 28
Total funding $2,122,779

Click on a grant title below to expand the full details for that specific grant.


20161 grants / $23,750

Circulating exosomes in pancreatic cancer as a source of novel diagnostic biomarkers$23,750

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Associate Professor Christopher Scarlett, Doctor Jude Weidenhofer, Doctor Kelly Kiejda
Scheme Project Grant
Role Investigator
Funding Start 2016
Funding Finish 2016
GNo G1601070
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

20154 grants / $450,805

The Hunter Cancer Biobank (HCB): Maximising community value through validation, annotation and distribution throughout NSW$300,000

Funding body: Cancer Institute NSW

Funding body Cancer Institute NSW
Project Team Professor Marjorie Walker, Conjoint Professor Stephen Ackland, Laureate Professor Rodney Scott, Professor John Forbes, Professor Xu Dong Zhang, Doctor Pradeep Tanwar, Doctor Nikola Bowden, Doctor Craig Gedye, Doctor James Lynam, Doctor Kelly Kiejda, Doctor Jennette Sakoff, Mr Loui Rassam, Dr Tara Roberts, Professor Soon Lee, Dr Betty Kan
Scheme Research Infrastructure Grants
Role Investigator
Funding Start 2015
Funding Finish 2018
GNo G1500825
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

Live cell imager for enhancement of pre-clinical cancer studies in the Hunter Translational Cancer Research Centre$124,938

Funding body: Cancer Institute NSW

Funding body Cancer Institute NSW
Project Team Conjoint Professor Stephen Ackland, Doctor Kelly Kiejda, Associate Professor Kevin Spring, Professor Xu Dong Zhang, Associate Professor Deborah Marsh, Associate Professor Christopher Scarlett, Doctor Pradeep Tanwar, Doctor Kathryn Skelding, Doctor Rick Thorne, Doctor Nikola Bowden
Scheme Research Equipment Grant
Role Investigator
Funding Start 2015
Funding Finish 2016
GNo G1500598
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

Live cell imager for enhancement of pre-clinical cancer studies in the Hunter Translational Cancer Research Centre$25,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Conjoint Professor Stephen Ackland, Doctor Kelly Kiejda, Associate Professor Kevin Spring, Professor Xu Dong Zhang, Associate Professor Deborah Marsh, Associate Professor Christopher Scarlett, Doctor Pradeep Tanwar, Doctor Kathryn Skelding, Doctor Rick Thorne, Doctor Nikola Bowden
Scheme Equipment Grant
Role Investigator
Funding Start 2015
Funding Finish 2015
GNo G1500953
Type Of Funding Internal
Category INTE
UON Y

Familial Aspects of Cancer 2015 Research and Practice, Mantra on Salt Beach, Kingscliff, 26 - 28 August 2015$867

Funding body: University of Newcastle - Faculty of Health and Medicine

Funding body University of Newcastle - Faculty of Health and Medicine
Project Team Doctor Kelly Kiejda
Scheme Travel Grant
Role Lead
Funding Start 2015
Funding Finish 2015
GNo G1501069
Type Of Funding Internal
Category INTE
UON Y

20142 grants / $145,199

Visualisation of microparticles for development of biomarkers and targeted drug delivery mechanisms$125,199

Funding body: Cancer Institute NSW

Funding body Cancer Institute NSW
Project Team Associate Professor Christopher Scarlett, Doctor Kathryn Skelding, Doctor Jude Weidenhofer, Doctor Matt Dun, Doctor Kelly Kiejda, Professor Adam McCluskey, Ms Elham Sadeqzadeh, Professor Hubert Hondermarck, Doctor Rick Thorne, Laureate Professor Rodney Scott
Scheme Research Equipment Grant
Role Investigator
Funding Start 2014
Funding Finish 2014
GNo G1400627
Type Of Funding Other Public Sector - State
Category 2OPS
UON Y

A new frontier in breast cancer: Can small molecules in the blood predict outcome?$20,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor Kelly Kiejda, Doctor Jude Weidenhofer, Laureate Professor Rodney Scott
Scheme Project Grant
Role Lead
Funding Start 2014
Funding Finish 2014
GNo G1401454
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

20132 grants / $40,000

The function of the delta-40p53 isoform in breast cancer.$30,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor Kelly Kiejda, Miss Brianna Morten, Laureate Professor Rodney Scott
Scheme Project Grant
Role Lead
Funding Start 2013
Funding Finish 2013
GNo G1300583
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

miRNA regulation of growth, invasion and treatment response in triple negative breast cancer$10,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor Kelly Kiejda, Doctor Andrea Mathe
Scheme Project Grant
Role Lead
Funding Start 2013
Funding Finish 2013
GNo G1300728
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

20125 grants / $484,300

Small p53 isoforms, BIG implications for treatment response in breast cancer$90,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor Kelly Kiejda, Laureate Professor Rodney Scott
Scheme Project Grant
Role Lead
Funding Start 2012
Funding Finish 2015
GNo G1200322
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

p53 isoforms in breast cancer - MM Sawyer Estate Scholarship$85,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor Kelly Kiejda, Laureate Professor Rodney Scott
Scheme Mary Minto Sawyer Grant
Role Lead
Funding Start 2012
Funding Finish 2014
GNo G1200615
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

2011 Emerging Research Leaders Program$15,000

Funding body: University of Newcastle

Funding body University of Newcastle
Project Team Doctor Kelly Kiejda
Scheme Emerging Research Leaders Program
Role Lead
Funding Start 2012
Funding Finish 2012
GNo G1200817
Type Of Funding Internal
Category INTE
UON Y

Ninth International NRAi, MicroRNAs & Single Cell Biology - 2012, Hilton Garden Inn, Waltham, Massachusetts, USA, 1 - 2 May 2012$2,000

Funding body: University of Newcastle - Faculty of Health and Medicine

Funding body University of Newcastle - Faculty of Health and Medicine
Project Team Doctor Kelly Kiejda
Scheme Travel Grant
Role Lead
Funding Start 2012
Funding Finish 2012
GNo G1200588
Type Of Funding Internal
Category INTE
UON Y

20113 grants / $50,375

p53 isoforms, a prognostic indicator in breast cancer?$45,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor Kelly Kiejda, Laureate Professor Rodney Scott, Professor John Forbes
Scheme Breast Cancer Project Grant
Role Lead
Funding Start 2011
Funding Finish 2011
GNo G1001006
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

PULSE Education Prize$4,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor Kelly Kiejda
Scheme PULSE Education Prize
Role Lead
Funding Start 2011
Funding Finish 2011
GNo G1001021
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

Annual meeting fo the Australasian Microarray & Associated Technologies Association (AMATA), Shine Dome in Canberra, 9 - 12 October 2011$1,375

Funding body: University of Newcastle - Faculty of Health and Medicine

Funding body University of Newcastle - Faculty of Health and Medicine
Project Team Doctor Kelly Kiejda
Scheme Travel Grant
Role Lead
Funding Start 2011
Funding Finish 2011
GNo G1100938
Type Of Funding Internal
Category INTE
UON Y

20101 grants / $21,600

The identification of microRNA's as therapeutic targets for the treatment of advanced breast cancer$21,600

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Doctor Kelly Kiejda, Laureate Professor Rodney Scott, Professor John Forbes
Scheme Research Grant
Role Lead
Funding Start 2010
Funding Finish 2010
GNo G0900144
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

20094 grants / $387,000

Targeting p53 isoforms, delta-40p53 and p53-beta, to promote chemo-sensitivity in human melanoma$272,000

Funding body: Cancer Council NSW

Funding body Cancer Council NSW
Project Team Professor Xu Dong Zhang, Conjoint Professor Peter Hersey, Doctor Kelly Kiejda
Scheme Research Grant
Role Investigator
Funding Start 2009
Funding Finish 2011
GNo G0188913
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON Y

Targeting p53 isoforms, delta-40p53 and p53-beta, to promote chemo-sensitivity in human melanoma$75,000

Funding body: Cancer Australia

Funding body Cancer Australia
Project Team Doctor Kelly Kiejda, Professor Xu Dong Zhang, Conjoint Professor Peter Hersey
Scheme Priority-driven Collaborative Cancer Research Scheme
Role Lead
Funding Start 2009
Funding Finish 2009
GNo G0188914
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON Y

Targeting p53 isoforms in human melanoma$30,000

Funding body: Calvary Mater Newcastle

Funding body Calvary Mater Newcastle
Project Team

Kelly Avery-Kiejda

Scheme Project Grant
Role Lead
Funding Start 2009
Funding Finish 2009
GNo
Type Of Funding Internal
Category INTE
UON N

The microRNA signature of endoplasmic reticulum stress in melanoma$10,000

Funding body: Calvary Mater Newcastle

Funding body Calvary Mater Newcastle
Project Team

XD Zhang

Scheme Project Grant
Role Investigator
Funding Start 2009
Funding Finish 2009
GNo
Type Of Funding Internal
Category INTE
UON N

20073 grants / $105,000

Characterization of p53 isoforms in human melanoma: do they play a role in chemoresistance?$75,000

Funding body: Cure Cancer Australia Foundation

Funding body Cure Cancer Australia Foundation
Project Team

XD Zhang

Scheme Research Grant
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo
Type Of Funding Grant - Aust Non Government
Category 3AFG
UON N

The role of p53 Isoforms in chemoresistances of human melanoma$20,000

Funding body: Hunter Medical Research Institute

Funding body Hunter Medical Research Institute
Project Team Professor Xu Dong Zhang, Doctor Kelly Kiejda
Scheme Project Grant
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo G0187239
Type Of Funding Contract - Aust Non Government
Category 3AFC
UON Y

The role of p53 isoforms in chemoresistance of human melanoma$10,000

Funding body: Calvary Mater Newcastle

Funding body Calvary Mater Newcastle
Project Team

XD Zhang

Scheme Project Grant
Role Investigator
Funding Start 2007
Funding Finish 2007
GNo
Type Of Funding Internal
Category INTE
UON N

20061 grants / $332,000

Cameron Fellowship in Melanoma Research$332,000

Funding body: Melanoma and Skin Cancer Research Institute

Funding body Melanoma and Skin Cancer Research Institute
Project Team

Kelly Avery-Kiejda

Scheme fellowship
Role Lead
Funding Start 2006
Funding Finish 2009
GNo
Type Of Funding Internal
Category INTE
UON N

20012 grants / $82,750

Australian Postgraduate Award$64,750

Scholarship support for PhD

Funding body: Department of Education, Training & Youth Affairs

Funding body Department of Education, Training & Youth Affairs
Project Team

Kelly Avery

Scheme Scholarship support for PhD
Role Lead
Funding Start 2001
Funding Finish 2004
GNo
Type Of Funding Aust Competitive - Commonwealth
Category 1CS
UON N

Millennium Foundation Stipend Enhancement Grant$18,000

Funding body: Millennium Foundation

Funding body Millennium Foundation
Project Team

Kelly Avery

Scheme Stipend enhancement grant
Role Lead
Funding Start 2001
Funding Finish 2004
GNo
Type Of Funding Not Known
Category UNKN
UON N
Edit

Research Supervision

Number of supervisions

Completed5
Current4

Total current UON EFTSL

PhD2

Current Supervision

Commenced Level of Study Research Title Program Supervisor Type
2017 PhD Isoforms of TP53 and Their Role in Breast Cancer Development and Progression PhD (Medical Genetics), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2016 PhD Genomic Assessment of the Positive Sentinel Node in Breast Cancer PhD (Medical Genetics), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2015 PhD The Function of ¿40p53 in Breast Cancer PhD (Medical Genetics), Faculty of Health and Medicine, The University of Newcastle Principal Supervisor
2015 PhD Circulating Exosomes in Pancreatic Cancer as a Source of Novel Diagnostic Biomarkers PhD (Biological Sciences), Faculty of Science, The University of Newcastle Co-Supervisor

Past Supervision

Year Level of Study Research Title Program Supervisor Type
2017 PhD The Regulation, Function and Expression of delta40p53 in Breast Cancer PhD (Medical Genetics), Faculty of Health and Medicine, The University of Newcastle Principal Supervisor
2016 PhD The Role of Short Tandem Repeats in Genetic Susceptibility to Breast and Endometrial Cancers PhD (Medical Genetics), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2016 PhD Genetic and Epigenetic Changes Associated with the Development of Lymph Node Metastasis in Triple Negative Breast Cancer PhD (Medical Genetics), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2014 PhD The Contribution of Genetic Susceptibility to Breast Cancer PhD (Medical Genetics), Faculty of Health and Medicine, The University of Newcastle Co-Supervisor
2011 Honours p53 isoforms in breast cancer Medical Science, University of Newcastle Principal Supervisor
Edit

Dr Kelly Kiejda

Position

Research Fellow
Information Based Medicine
School of Biomedical Sciences and Pharmacy
Faculty of Health and Medicine

Focus area

Medical Genetics

Contact Details

Email kelly.kiejda@newcastle.edu.au
Phone 4042 0309
Fax 4042 0031

Office

Room Rm 3104, Lvl 3, West
Building Hunter Medical Research Institute
Location Lot 1 Kookaburra Circuit, New Lambton Heights, NSW 2305

,
Edit